195 related articles for article (PubMed ID: 31703155)
21. Test-retest repeatability of a deep learning architecture in detecting and segmenting clinically significant prostate cancer on apparent diffusion coefficient (ADC) maps.
Hiremath A; Shiradkar R; Merisaari H; Prasanna P; Ettala O; Taimen P; Aronen HJ; Boström PJ; Jambor I; Madabhushi A
Eur Radiol; 2021 Jan; 31(1):379-391. PubMed ID: 32700021
[TBL] [Abstract][Full Text] [Related]
22. Prediction of prostate cancer aggressiveness with a combination of radiomics and machine learning-based analysis of dynamic contrast-enhanced MRI.
Liu B; Cheng J; Guo DJ; He XJ; Luo YD; Zeng Y; Li CM
Clin Radiol; 2019 Nov; 74(11):896.e1-896.e8. PubMed ID: 31495546
[TBL] [Abstract][Full Text] [Related]
23. Reliability of MRI radiomics features in MR-guided radiotherapy for prostate cancer: Repeatability, reproducibility, and within-subject agreement.
Xue C; Yuan J; Poon DM; Zhou Y; Yang B; Yu SK; Cheung YK
Med Phys; 2021 Nov; 48(11):6976-6986. PubMed ID: 34562286
[TBL] [Abstract][Full Text] [Related]
24. Machine learning-based analysis of [
Cysouw MCF; Jansen BHE; van de Brug T; Oprea-Lager DE; Pfaehler E; de Vries BM; van Moorselaar RJA; Hoekstra OS; Vis AN; Boellaard R
Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):340-349. PubMed ID: 32737518
[TBL] [Abstract][Full Text] [Related]
25. Comparing diagnostic accuracy of luminal water imaging with diffusion-weighted and dynamic contrast-enhanced MRI in prostate cancer: A quantitative MRI study.
Sabouri S; Chang SD; Goldenberg SL; Savdie R; Jones EC; Black PC; Fazli L; Kozlowski P
NMR Biomed; 2019 Feb; 32(2):e4048. PubMed ID: 30575145
[TBL] [Abstract][Full Text] [Related]
26. The Effect of Image Resampling on the Performance of Radiomics-Based Artificial Intelligence in Multicenter Prostate MRI.
Bleker J; Roest C; Yakar D; Huisman H; Kwee TC
J Magn Reson Imaging; 2024 May; 59(5):1800-1806. PubMed ID: 37572098
[TBL] [Abstract][Full Text] [Related]
27. Predicting the Grade of Prostate Cancer Based on a Biparametric MRI Radiomics Signature.
Zhang L; Zhe X; Tang M; Zhang J; Ren J; Zhang X; Li L
Contrast Media Mol Imaging; 2021; 2021():7830909. PubMed ID: 35024015
[TBL] [Abstract][Full Text] [Related]
28. Radiomic features on MRI enable risk categorization of prostate cancer patients on active surveillance: Preliminary findings.
Algohary A; Viswanath S; Shiradkar R; Ghose S; Pahwa S; Moses D; Jambor I; Shnier R; Böhm M; Haynes AM; Brenner P; Delprado W; Thompson J; Pulbrock M; Purysko AS; Verma S; Ponsky L; Stricker P; Madabhushi A
J Magn Reson Imaging; 2018 Feb; ():. PubMed ID: 29469937
[TBL] [Abstract][Full Text] [Related]
29. Prostate Cancer Differentiation and Aggressiveness: Assessment With a Radiomic-Based Model vs. PI-RADS v2.
Chen T; Li M; Gu Y; Zhang Y; Yang S; Wei C; Wu J; Li X; Zhao W; Shen J
J Magn Reson Imaging; 2019 Mar; 49(3):875-884. PubMed ID: 30230108
[TBL] [Abstract][Full Text] [Related]
30. Magnetic Resonance Imaging Radiomics-Based Machine Learning Prediction of Clinically Significant Prostate Cancer in Equivocal PI-RADS 3 Lesions.
Hectors SJ; Chen C; Chen J; Wang J; Gordon S; Yu M; Al Hussein Al Awamlh B; Sabuncu MR; Margolis DJA; Hu JC
J Magn Reson Imaging; 2021 Nov; 54(5):1466-1473. PubMed ID: 33970516
[TBL] [Abstract][Full Text] [Related]
31. Radiomics Driven Diffusion Weighted Imaging Sensing Strategies for Zone-Level Prostate Cancer Sensing.
Dulhanty C; Wang L; Cheng M; Gunraj H; Khalvati F; Haider MA; Wong A
Sensors (Basel); 2020 Mar; 20(5):. PubMed ID: 32164378
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
[TBL] [Abstract][Full Text] [Related]
33. Radiomics Based on MRI as a Biomarker to Guide Therapy by Predicting Upgrading of Prostate Cancer From Biopsy to Radical Prostatectomy.
Zhang GM; Han YQ; Wei JW; Qi YF; Gu DS; Lei J; Yan WG; Xiao Y; Xue HD; Feng F; Sun H; Jin ZY; Tian J
J Magn Reson Imaging; 2020 Oct; 52(4):1239-1248. PubMed ID: 32181985
[TBL] [Abstract][Full Text] [Related]
34. Bi-parametric magnetic resonance imaging based radiomics for the identification of benign and malignant prostate lesions: cross-vendor validation.
Ji X; Zhang J; Shi W; He D; Bao J; Wei X; Huang Y; Liu Y; Chen JC; Gao X; Tang Y; Xia W
Phys Eng Sci Med; 2021 Sep; 44(3):745-754. PubMed ID: 34075559
[TBL] [Abstract][Full Text] [Related]
35. [Discussion of correlation between histogram analysis of quantitative diffusion weighted imaging and Gleason score of prostate cancer].
Wen R; Zhao WL; Wei CG; Gu YF; Li MJ; Zhang YY; Shen JK
Zhonghua Yi Xue Za Zhi; 2019 Mar; 99(11):823-828. PubMed ID: 30893724
[No Abstract] [Full Text] [Related]
36. Fitting methods for intravoxel incoherent motion imaging of prostate cancer on region of interest level: Repeatability and gleason score prediction.
Merisaari H; Movahedi P; Perez IM; Toivonen J; Pesola M; Taimen P; Boström PJ; Pahikkala T; Kiviniemi A; Aronen HJ; Jambor I
Magn Reson Med; 2017 Mar; 77(3):1249-1264. PubMed ID: 26924552
[TBL] [Abstract][Full Text] [Related]
37. Risk Stratification of Prostate Cancer Using the Combination of Histogram Analysis of Apparent Diffusion Coefficient Across Tumor Diffusion Volume and Clinical Information: A Pilot Study.
Zhang Z; Xu H; Xue Y; Li J; Ye Q
J Magn Reson Imaging; 2019 Feb; 49(2):556-564. PubMed ID: 30173421
[TBL] [Abstract][Full Text] [Related]
38. Multi-parametric MRI-based radiomics signature for discriminating between clinically significant and insignificant prostate cancer: Cross-validation of a machine learning method.
Min X; Li M; Dong D; Feng Z; Zhang P; Ke Z; You H; Han F; Ma H; Tian J; Wang L
Eur J Radiol; 2019 Jun; 115():16-21. PubMed ID: 31084754
[TBL] [Abstract][Full Text] [Related]
39. Diffusion Kurtosis Imaging Combined With DWI at 3-T MRI for Detection and Assessment of Aggressiveness of Prostate Cancer.
Wang X; Tu N; Qin T; Xing F; Wang P; Wu G
AJR Am J Roentgenol; 2018 Oct; 211(4):797-804. PubMed ID: 30085835
[TBL] [Abstract][Full Text] [Related]
40. Characterisation of prostate cancer using texture analysis for diagnostic and prognostic monitoring.
Singh D; Kumar V; Das CJ; Singh A; Mehndiratta A
NMR Biomed; 2021 Jun; 34(6):e4495. PubMed ID: 33638244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
